STAT+: OpenEvidence will add FDA-cleared AI to detect heart disease

OpenEvidence's integration of FDA-cleared AI for detecting heart disease marks a significant leap in medical diagnostics, potentially enabling earlier and more accurate identification of cardiovascular issues. This innovation could revolutionize preventive healthcare by catching conditions sooner, reducing the burden on healthcare systems, and improving patient outcomes. The move underscores the growing role of artificial intelligence in transforming medical practices and highlights the potential for tech-driven advancements to address critical health challenges.